U.S. Physical Therapy, Inc. (USPH) Earns “Buy” Rating from Cantor Fitzgerald
U.S. Physical Therapy, Inc. (NYSE:USPH)‘s stock had its “buy” rating reissued by Cantor Fitzgerald in a research note issued to investors on Thursday. They presently have a $74.00 price target on the stock. Cantor Fitzgerald’s price target would suggest a potential upside of 8.90% from the stock’s current price.
The analysts wrote, “Storm impact contained, outlook fine. Hurricanes cost an estimated $0.03 per share in 3Q17, fully diluted EPS were $0.48 (vs. our $0.52 estimate), and we are reducing our full year 2017 estimate to $2.10 (from $2.15). We are raising our 2018 estimate to $2.45 (from $2.40). Our corresponding full year adjusted EBITDA estimates (3Q17 results were about $900,000 shy of our $14.6 million estimate) are $57.7 million for 2017 (vs. prior $58.6 million) and $65.5 million (vs. prior $63.7 million ) for 2018. Commercial reimbursement rates look fine for 2018; the average reimbursement for commercial is $100 vs. Medicare’s $90.””
USPH has been the subject of a number of other research reports. BidaskClub raised U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a report on Thursday, September 28th. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 price target on the stock in a research report on Tuesday, August 29th. Jefferies Group LLC set a $65.00 price target on U.S. Physical Therapy and gave the company a “hold” rating in a research report on Friday, August 4th. Finally, Sidoti upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the company from $62.00 to $74.00 in a research report on Friday, September 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $69.00.
U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.01). U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. The firm had revenue of $104.25 million during the quarter, compared to analyst estimates of $102.93 million.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/02/u-s-physical-therapy-inc-usph-earns-buy-rating-from-cantor-fitzgerald.html.
In related news, CFO Lawrance W. Mcafee sold 3,000 shares of the company’s stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $62.04, for a total transaction of $186,120.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Glenn Mcdowell sold 1,004 shares of the company’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $57.01, for a total value of $57,238.04. The disclosure for this sale can be found here. Insiders sold a total of 13,266 shares of company stock worth $801,134 in the last quarter. Corporate insiders own 3.10% of the company’s stock.
Several institutional investors have recently made changes to their positions in USPH. Pinebridge Investments L.P. boosted its position in shares of U.S. Physical Therapy by 1.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock valued at $100,000 after purchasing an additional 17 shares in the last quarter. State of Alaska Department of Revenue raised its stake in U.S. Physical Therapy by 77.8% during the 2nd quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after buying an additional 1,074 shares during the period. Sei Investments Co. raised its stake in U.S. Physical Therapy by 31.8% during the 2nd quarter. Sei Investments Co. now owns 2,576 shares of the company’s stock worth $155,000 after buying an additional 622 shares during the period. Municipal Employees Retirement System of Michigan raised its stake in U.S. Physical Therapy by 3.1% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after buying an additional 90 shares during the period. Finally, Oppenheimer Asset Management Inc. acquired a new position in U.S. Physical Therapy during the 1st quarter worth approximately $221,000. Institutional investors own 94.56% of the company’s stock.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.